AZD6793 Clinical Trials (2026): 5 Studies for Healthy Participants & Chronic Obstructive Pulmonary Disease (COPD)

Hipa.ai Research · Source: ClinicalTrials.gov / AACT

Synced daily from ClinicalTrials.gov via AACT. Last sync: .

5 AZD6793 clinical trials are catalogued on Hipa.ai from the AACT mirror of ClinicalTrials.gov, spanning 4 indications (including Healthy Participants & Chronic Obstructive Pulmonary Disease (COPD)) and 1,164 total planned enrollment. 1 AZD6793 clinical trial is actively recruiting at 75 U.S. sites across 24 states. Most recent activity: NCT07082738 (Nov 2027).

Where to Participate: All AZD6793 Trial Sites in the U.S. (75 sites across 24 states)

Every actively recruiting AZD6793trial site, sorted by state then city. Each row links to the trial detail page (eligibility, contacts, full study record). Sites no longer enrolling at the location level are excluded. ClinicalTrials.gov / AACT does not provide street-level addresses; the map link uses the facility's geocoded coordinates where available.

StateFacilityCityTrialMap
ALResearch SiteBirmingham35205NCT07082738Map
AZResearch SitePhoenix85027NCT07082738Map
AZResearch SitePhoenix85044NCT07082738Map
AZResearch SitePhoenix85051NCT07082738Map
CAResearch SiteLos Angeles90017NCT07082738Map
CAResearch SiteNewport Beach92663NCT07082738Map
CAResearch SiteNorco92860NCT07082738Map
CAResearch SiteTustin92780NCT07082738Map
FLResearch SiteBrandon33511NCT07082738Map
FLResearch SiteCape Coral33990NCT07082738Map
FLResearch SiteClearwater33756NCT07082738Map
FLResearch SiteClearwater33765NCT07082738Map
FLResearch SiteLake City32055NCT07082738Map
FLResearch SiteMiami33125NCT07082738Map
FLResearch SiteMiami33155NCT07082738Map
FLResearch SiteMiami33173NCT07082738Map
FLResearch SiteMiami33175NCT07082738Map
FLResearch SiteMiami33182NCT07082738Map
FLResearch SiteMiami Lakes33014NCT07082738Map
FLResearch SiteNaples34102NCT07082738Map
FLResearch SiteOcala34471NCT07082738Map
FLResearch SiteOrmond Beach32174NCT07082738Map
FLResearch SitePlantation33324NCT07082738Map
FLResearch SiteSarasota34239NCT07082738Map
FLResearch SiteTamarac33321NCT07082738Map
FLResearch SiteTampa33606NCT07082738Map
FLResearch SiteTampa33607NCT07082738Map
FLResearch SiteWinter Park32789NCT07082738Map
GAResearch SiteSuwanee30024NCT07082738Map
LAResearch SiteZachary70791NCT07082738Map
MDResearch SiteBaltimore21201NCT07082738Map
MDResearch SiteBaltimore21224NCT07082738Map
MAResearch SiteBurlington01805NCT07082738Map
MIResearch SiteFarmington Hills48336NCT07082738Map
MIResearch SiteGarden City48135NCT07082738Map
MIResearch SiteGrand Rapids49546NCT07082738Map
MOResearch SiteChesterfield63005NCT07082738Map
MOResearch SiteHannibal63401NCT07082738Map
MOResearch SiteSt Louis63110NCT07082738Map
MOResearch SiteSt Louis63141NCT07082738Map
MTResearch SiteKalispell59901NCT07082738Map
NCResearch SiteNew Bern28562NCT07082738Map
OHResearch SiteMarion43302NCT07082738Map
OKResearch SiteOklahoma City73104NCT07082738Map
OKResearch SiteTulsa74133NCT07082738Map
ORResearch SiteMedford97504NCT07082738Map
ORResearch SitePortland97202NCT07082738Map
PAResearch SiteCamp Hill17011NCT07082738Map
PAResearch SiteDuBois15801NCT07082738Map
PAResearch SitePhiladelphia19114NCT07082738Map
PAResearch SitePhiladelphia19140NCT07082738Map
PAResearch SitePittsburgh15213NCT07082738Map
PAResearch SiteScottdale15683NCT07082738Map
PAResearch SiteSmithfield15478NCT07082738Map
SCResearch SiteLancaster29720NCT07082738Map
SCResearch SiteSpartanburg29303NCT07082738Map
SDResearch SiteRapid City57702NCT07082738Map
TNResearch SiteChattanooga37421NCT07082738Map
TNResearch SiteFranklin37067NCT07082738Map
TNResearch SiteJohnson City37604NCT07082738Map
TXResearch SiteBoerne78006NCT07082738Map
TXResearch SiteDallas75254NCT07082738Map
TXResearch SiteDenison75020NCT07082738Map
TXResearch SiteEl Paso79902NCT07082738Map
TXResearch SiteHouston77002NCT07082738Map
TXResearch SiteHouston77008NCT07082738Map
TXResearch SiteKingwood77339NCT07082738Map
TXResearch SiteLewisville75067NCT07082738Map
TXResearch SiteMansfield76063NCT07082738Map
TXResearch SiteMcKinney75069NCT07082738Map
VTResearch SiteColchester05446NCT07082738Map
VAResearch SiteNorfolk23504NCT07082738Map
VAResearch SiteWilliamsburg23188NCT07082738Map
WVResearch SiteMorgantown26505NCT07082738Map
WIResearch SiteMadison53715NCT07082738Map

AZD6793 clinical trials at a glance: phase × recruitment status

PhaserecruitingcompletedsuspendedTotal
P1314
P211

Recruiting AZD6793 clinical trials (1)

Studies currently enrolling participants. Click any NCT ID to view the trial detail page (eligibility, sites, contacts).

NCT IDTitlePhaseIndicationEnrollmentStarted
NCT07082738PRESTOA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseP2Chronic Obstructive Pulmonary Disease (COPD)987Jun 2025

AZD6793 clinical trials by indication

Healthy Participants (2)

NCTAcronymPhaseStatusTitle
NCT06368440—P1completedA Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese Participants
NCT06494644—P1completedA Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.

Type 2 Diabetes Mellitus (1)

NCTAcronymPhaseStatusTitle
NCT07433062IRAK4P1suspendedA Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes Mellitus

Chronic Obstructive Pulmonary Disease (COPD) (1)

NCTAcronymPhaseStatusTitle
NCT07082738PRESTOP2recruitingA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease

Inflammatory Diseases (1)

NCTAcronymPhaseStatusTitle
NCT05662033PKP1completedA Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.

AZD6793 pivotal trial highlights (Phase 2/3/4)

Phase-2/3/4 studies with named acronyms — the registration-grade trials most cited in label discussions and Wikipedia.

AcronymNCTPhaseStatusIndicationEnrollmentPubMed
PRESTONCT07082738P2recruitingChronic Obstructive Pulmonary Disease (COPD)987—

Terminated and withdrawn AZD6793 trials (1)

Studies that ended before completion. Reasons are filed in each trial's ClinicalTrials.gov entry.

All AZD6793 trials (5)

Sorted by most recent activity (completion → start → posted date). Each row links to the trial detail page on Hipa.ai.

NCT IDAcronymTitlePhaseStatusEnrollmentSponsorStarted
NCT07082738PRESTOA Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary DiseaseP2recruiting987AstraZenecaJun 2025
NCT07433062IRAK4A Study to Evaluate the Effect of AZD6793 on the Pharmacokinetics and Pharmacodynamics of Metformin in Participants With Type 2 Diabetes MellitusP1suspended28AstraZenecaJan 2026
NCT06368440A Study to Investigate the Safety and Pharmacokinetics of AZD6793 in Healthy Japanese and Chinese ParticipantsP1completed39AstraZenecaMay 2024
NCT05662033PKA Study to Investigate the Safety, Tolerability, and Pharmacokinetics (PK) of Oral AZD6793 in Healthy and Chronic Obstructive Pulmonary Disease Participants, to Assess the Relative Oral Bioavailability Between Two Formulations, and the Food Effect on the PK of AZD6793 Compared to Fasting State.P1completed93AstraZenecaDec 2022
NCT06494644A Study to Assess the Pharmacokinetics of AZD6793 When Administered Alone and in Combination With Itraconazole in Healthy Participants.P1completed17AstraZenecaJul 2024

AZD6793 clinical trials: frequently asked questions

How many AZD6793 clinical trials are there?
5 AZD6793 clinical trials are catalogued on Hipa.ai, sourced from the AACT mirror of ClinicalTrials.gov. 1 is actively recruiting participants. 3 are marked completed.
Are AZD6793 clinical trials recruiting in 2026?
Yes — 1 AZD6793 trial is actively recruiting in 2026, with 75 U.S. sites across 24 states. See the recruiting trials and the per-state site list further down this page.
What conditions is AZD6793 being studied for?
AZD6793 is being studied for Healthy Participants, Chronic Obstructive Pulmonary Disease (COPD), Inflammatory Diseases, Type 2 Diabetes Mellitus. The trials are grouped by indication on this page.
What phase is AZD6793 in?
AZD6793 clinical trials span 1 Phase 2, 4 Phase 1. The phase × status matrix at the top of this page breaks down counts by phase and recruitment status.
Who sponsors AZD6793 clinical trials?
The lead sponsor across the most AZD6793 trials is AstraZeneca. Each trial row links to the full study detail page including sponsor information.

Sources and methodology

Trial inventory derived from the AACT mirror of ClinicalTrials.gov. Trials are filtered to those naming AZD6793as an intervention. Phase, status, enrollment, sponsor, and dates are taken from the source `studies` table; primary indication is the first listed condition. Acronyms are extracted from each trial's brief title where present. PubMed links are populated for trials whose published primary outcomes have been indexed in our evidence cache.

Last refreshed .

Related pages on Hipa.ai:

AZD6793 overview